WO1991018646A1 - A device and method for laser photothermotherapy - Google Patents

A device and method for laser photothermotherapy Download PDF

Info

Publication number
WO1991018646A1
WO1991018646A1 PCT/GB1991/000862 GB9100862W WO9118646A1 WO 1991018646 A1 WO1991018646 A1 WO 1991018646A1 GB 9100862 W GB9100862 W GB 9100862W WO 9118646 A1 WO9118646 A1 WO 9118646A1
Authority
WO
WIPO (PCT)
Prior art keywords
laser
pulse
tissue
local
heating
Prior art date
Application number
PCT/GB1991/000862
Other languages
French (fr)
Inventor
Costas Diamantopoulos
Vladilen Letokhov
Original Assignee
European Industries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by European Industries Limited filed Critical European Industries Limited
Publication of WO1991018646A1 publication Critical patent/WO1991018646A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/062Photodynamic therapy, i.e. excitation of an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/067Radiation therapy using light using laser light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00137Details of operation mode
    • A61B2017/00154Details of operation mode pulsed
    • A61B2017/00194Means for setting or varying the repetition rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0635Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0643Applicators, probes irradiating specific body areas in close proximity
    • A61N2005/0644Handheld applicators

Definitions

  • the present invention relates to a device for laser photothermotherapy comprising a pulsed laser constructed to operate in the ultraviolet, visible or infrared portion of the spectrum, and a system arranged to deliver pulsed irradiation generated from said laser to a targeted area of living human or animal tissue.
  • All devices and methods of using laser light for therapeutic and surgical purposes can be divided into two classes, depending on whether the laser-exposed biotissue suffers thermal damage upon absorption of radiation or not.
  • Such a classification embraces all types of lasers, both pulsed and continuous-wave, for which the maximum permissible heating temperature of biotissue that, still does not cause damage depends on the length of time that the biotissue stays heated.
  • the non-destructive class includes devices and methods which use low-intensity laser or incoherent radiation causing biostimulation without perceptible heating and find successful application in curing many a disease (the photomedical fundamentals of the method have been described in Laser Science and Technology - An International Handbook, Vol.8 (Harwood Acad. Publ., 1989) p189 under the heading Photobiology of Low-Power Laser Therapy by T T Karu). Means for phototherapy with lowintensity light are the subject-matter of a number of inventions by Omega University Technologies Limited. This class also includes photodynamic therapy means and methods which utilize the photochemical action of sensitizers introduced in biotissue.
  • the destructive class includes devices and methods which use high-intensity continuous-wave or pulsed radiation causing a substantial heating of biotissue.
  • High-intensity continuous-wave laser radiation absorbed by biotissue causes its heating and destruction (coagulation, carbonization, pyrolysis, and evaporation as temperature grows higher). This is employed in the laser thermal surgery of soft biotissue.
  • High-intensity pulsed laser radiation at a wavelength of strong absorption by biotissue causes its high pulsed overheating, followed by vaporizing ablation. This is used for destruction of biotissue, both soft and hard (bones, atherosolerotic plaques).
  • An object of the present invention is to provide a device and method for photothermotherapy whereby high- intensity laser radiation can be absorbed by biotissue in controlled conditions without unsatisfactory heating of the entire laser-exposed volume of biotissue.
  • a device for laser photothermotherapy as defined in the first paragraph of this specification is characterised in that control means are provided for controlling said laser to generate pulses of variable duration, repetition rate and pulse duration between the pulses, and that measuring means responsive to the tissue, when irradiated, are provided for operating said control means for the pulse duration and wavelength delivered by said laser to correspond to exogenous or endogenous chromophores in the tissue, said measuring means being responsive to local microheating of an absorbing said chromophore or chromophores and the surrounding local microregion, significantly higher than the average temperature of the entire targeted tissue, for actuating said control means to render the pauses between consecutive laser pulses to be sufficiently long to permit cooling of the temperature elevation in said local microregion between each pulse and the next.
  • a chromophore is defined as a molecule that absorbs light at a specific wavelength.
  • a method of laser photothermotherapy comprises delivering ultraviolet, visible or infrared laser pulse energy to a targeted area of living human or animal tissue by means of the device defined above.
  • Figure 1 is an explanatory graph showing tissue destruction as a function of time and temperature
  • Figure 2 is a graph relating laser pulse fluence or radiation energy density and laser pulse duration and showing regions of laser radiation parameters
  • Figure 3(a) is a graph showing laser light intensity as a function of time
  • Figure 3(b) is a graph showing bio-tissue temperature variation in relation to laser pulses.
  • Figure 4 is a schematic diagram of a device for photothermotherapy.
  • the area beneath the curve covers the range of relationships between temperature and duration whereby permissible heating temperture of biotissue can be effected without causing damage to the tissue.
  • the region I covering laser photochemical reactions that are non-destructive (as well as photodynamical therapy and biostimulation) is related to the curve of Figure 1.
  • the parameter range of radiation of laser surgery is denoted by region II in Figure 2 where high-intensity continuous-wave laser radiation absorbed by bio-tissue causes its heating and destruction as by vaporization and coagulation.
  • the parameter region of laser radiation for ablation surgery is denoted by symbol III in Figure 2. Both regions II and III constitutute the destructive class of laser photochemical reactions.
  • Biotissue is characterised by its volume-averaged absorption per unit length, ⁇ o , and attenuation per unit length. A, which somewhat exceeds ⁇ o because of scattering. As a result, laser radiation penetrates biotissue to a depth of z o ⁇ 1/A. Owing to absorption of radiation, biotissue gets heated by an amount of ⁇ T, and then cools by diffusion during the time
  • Biotissue has local absorption inhomogeneities of varying size: of the order of a few nanometers (biomolecules), a few tens of nanometers (biomolecular aggregation, membrane thickness), a few microns (cells and subcellular units), and more (microcapillaries). If a local absorption microregion has an absorptivity of ⁇ loc exceeding the volume-averaged absorptivity ⁇ o ' it can be heated with a laser pulse by an amount of ⁇ T1oc exceeding the volume-averaged heating ⁇ T.
  • the cooling time T1 oc of the local overheating microregion is determined by its size 1: T1oc ⁇ I 2 /4x ( 3 )
  • the duration T p of the laser pulse used must be shorter than 2 ns. If the laser pulse fluence permissible from the standpoint of the volume- averaged non-destructive heating is, according to the above numerical example, ⁇ ma ⁇ ⁇ 4 J/cm 2 , the peak intensity of the ultrashort laser pulse is 1 p ⁇ ⁇ max /T ⁇ ⁇ 2 x 10 9 W/CM 2 . This intensity value is quite permissible, but it is fairly close to the threshold marking the onset of multiple-photon absorption effects.
  • the laser pulse duration must be shorter, in accordance with equation (3), and to prevent multiple-photon effects in the bulk of biotissue, the laser energy must be distributed among several pulses within the time interval T cool' so as to ensure that the peak intensity does not perceptibly exceed the value of 1 P ⁇ 2x10 9 W/cm 2 .
  • the laser energy must be distributed among several pulses within the time interval T cool' so as to ensure that the peak intensity does not perceptibly exceed the value of 1 P ⁇ 2x10 9 W/cm 2 .
  • the peak laser intensity will be lower than 10 9 W/cm 2 , radiation energy can be deposited in biotissue with single pulses. The interval between them in this case must not exceed Tcool in order to avoid destructive volume-averaged heating of biotissue.
  • Figure 3a shows the laser pulse sequence and Figure 3b, the temporal variation of the temperature of the exposed medium, caused by both the local heating ⁇ T 1oc of the microregions of increased absoption and the volume- averaged heating ⁇ T of the tissue.
  • the volume-averaged laser heating can accumulate during a long period of Tcool , if the cooling time is much longer than the interval T rep between the pulses.
  • the local heating of the microregions of increased absorption rapidly vanishes within the time T1oc ⁇ T rep .
  • ⁇ he average heating ⁇ T of the exposed region during the timeTcool must not exceed a maxium value of ⁇ T max .
  • a device for laser photothermotherapy includes a pulsed laser 1 whose wavelength ⁇ corresponds to that of local absorption by microregions of average size 1 ( ⁇ ) in biotissue, a laser pulse duration control unit 2 providing for the generation of laser pulses with a duration of T P satisfying the condition
  • T P ⁇ T 1oc /2( ⁇ )/4X (6) and a repetition period of T rep meeting the requirement for the absence of any noticeable volume-averaged heating of biotissue:
  • T rep ⁇ Tcool ( ⁇ )/4X ⁇ 1/[4 ⁇ ( ⁇ ) ]X (7) a delivery system 3 to deliver radiation to a biotissue treatment region that ensures the necessary laser pulse fluence ⁇ p ⁇ ⁇ T max Pc/ ⁇ o ( 8 ) with which the volume-averaged heating of biotissue falls within permissible limits, ⁇ T max ' while the pulsed local heating of the microregions in the tissue reaches therapeutic levels ( ⁇ T1oc > 15-50°C), and a rise and fall measurement unit 4 for measuring the local heating by a single laser pulse and the average heating ⁇ T by a train of laser pulses, which controls, by way of feedback to the control unit 2, the pulse energy and repetition period and the total exposure dose in order to provide for therapeutic effect without running the risk of thermal damage to the exposed tissue region.
  • the laser pulse repetition period is determined by the cooling time Tcool' whereas for 1 ⁇ 30 n, the pulse repetition period is selected to be shorter in order to limit the peak pulse intensity to a non-destructive level of some 2x10 9 W/cm 2 . In that case, the laser pulse fluence is limited to a safe average heating level of around 4 J/cm 2 .
  • the device can also be used in a method of laser photothermotherapy where tissue is injected by exogenak non-toxic dye or drug comprised by chromophores of suitable size to enable local micro-heating, on absorbing the effective wavelength, of the microregion where the chromophores of the dye or drug are situated and cause therapeutic or destructive effects according to the condition treated.

Abstract

Photothermotherapy is effected by pulsed ultraviolet, visible or infrared laser radiation passing through a system (3) that assures the necessary laser pulse fluence to a biotissue treatment region. While the pulsed local heating of microregions in the tissue reaches therapeutic levels a unit (4) measuring the local heating by a single pulse and the average heating by a train of pulses controls, by way of feedback, a control unit (2) which determines the pulse energy and repetition period and the total exposure dose to provide a required therapeutic effect without risk of thermal damage to the exposed tissue region.

Description

A DEVICE AND METHOD FOR LASER PHOTOTHERMOTHER APY
The present invention relates to a device for laser photothermotherapy comprising a pulsed laser constructed to operate in the ultraviolet, visible or infrared portion of the spectrum, and a system arranged to deliver pulsed irradiation generated from said laser to a targeted area of living human or animal tissue.
All devices and methods of using laser light for therapeutic and surgical purposes can be divided into two classes, depending on whether the laser-exposed biotissue suffers thermal damage upon absorption of radiation or not. Such a classification embraces all types of lasers, both pulsed and continuous-wave, for which the maximum permissible heating temperature of biotissue that, still does not cause damage depends on the length of time that the biotissue stays heated.
The non-destructive class includes devices and methods which use low-intensity laser or incoherent radiation causing biostimulation without perceptible heating and find successful application in curing many a disease (the photomedical fundamentals of the method have been described in Laser Science and Technology - An International Handbook, Vol.8 (Harwood Acad. Publ., 1989) p189 under the heading Photobiology of Low-Power Laser Therapy by T T Karu). Means for phototherapy with lowintensity light are the subject-matter of a number of inventions by Omega University Technologies Limited. This class also includes photodynamic therapy means and methods which utilize the photochemical action of sensitizers introduced in biotissue.
The destructive class includes devices and methods which use high-intensity continuous-wave or pulsed radiation causing a substantial heating of biotissue. High-intensity continuous-wave laser radiation absorbed by biotissue causes its heating and destruction (coagulation, carbonization, pyrolysis, and evaporation as temperature grows higher). This is employed in the laser thermal surgery of soft biotissue. High-intensity pulsed laser radiation at a wavelength of strong absorption by biotissue causes its high pulsed overheating, followed by vaporizing ablation. This is used for destruction of biotissue, both soft and hard (bones, atherosolerotic plaques).
An object of the present invention is to provide a device and method for photothermotherapy whereby high- intensity laser radiation can be absorbed by biotissue in controlled conditions without unsatisfactory heating of the entire laser-exposed volume of biotissue.
According to the invention, a device for laser photothermotherapy as defined in the first paragraph of this specification is characterised in that control means are provided for controlling said laser to generate pulses of variable duration, repetition rate and pulse duration between the pulses, and that measuring means responsive to the tissue, when irradiated, are provided for operating said control means for the pulse duration and wavelength delivered by said laser to correspond to exogenous or endogenous chromophores in the tissue, said measuring means being responsive to local microheating of an absorbing said chromophore or chromophores and the surrounding local microregion, significantly higher than the average temperature of the entire targeted tissue, for actuating said control means to render the pauses between consecutive laser pulses to be sufficiently long to permit cooling of the temperature elevation in said local microregion between each pulse and the next.
A chromophore is defined as a molecule that absorbs light at a specific wavelength.
According to another aspect of the invention, a method of laser photothermotherapy comprises delivering ultraviolet, visible or infrared laser pulse energy to a targeted area of living human or animal tissue by means of the device defined above.
In order that the invention may be clearly understood and readily carried into effect, a device and a method in accordance therewith will now be described, by way of example, with reference to the accompanying drawings, in which:
Figure 1 is an explanatory graph showing tissue destruction as a function of time and temperature;
Figure 2 is a graph relating laser pulse fluence or radiation energy density and laser pulse duration and showing regions of laser radiation parameters;
Figure 3(a) is a graph showing laser light intensity as a function of time;
Figure 3(b) is a graph showing bio-tissue temperature variation in relation to laser pulses; and
Figure 4 is a schematic diagram of a device for photothermotherapy.
Referring to Figure 1, the area beneath the curve covers the range of relationships between temperature and duration whereby permissible heating temperture of biotissue can be effected without causing damage to the tissue.
In Figure 2 the region I covering laser photochemical reactions that are non-destructive (as well as photodynamical therapy and biostimulation) is related to the curve of Figure 1. The parameter range of radiation of laser surgery is denoted by region II in Figure 2 where high-intensity continuous-wave laser radiation absorbed by bio-tissue causes its heating and destruction as by vaporization and coagulation. The parameter region of laser radiation for ablation surgery is denoted by symbol III in Figure 2. Both regions II and III constitutute the destructive class of laser photochemical reactions.
Recent investigations have revealed that account should be taken of the spatial absorption inhomogeneity of biotissue. The presence in biotissue of local microregions containing one or more chromophores characterised by increased absorption at certain radiation wavelengths makes it possible to effect their pulsed overheating without their being damaged and without any noticeable heating of the entire laser- exposed volume of biotissue. It is precisely this distinctive feature of biotissue that allows laser phototherapy to be implemented. The parameter region of radiation for laser photothermal therapy is denoted by symbol IV in Figure 2. The radiation parameters necessary for laser phototherapy differ from those for the other laser therapy (region I) and surgery (regions II and III) methods indicated above.
Arguments in favour of the existence of such a laser photothermotherapy method will now be given and the choice of the parameters of a means for its implementation explained. Biotissue is characterised by its volume-averaged absorption per unit length, η o , and attenuation per unit length. A, which somewhat exceeds η o because of scattering. As a result, laser radiation penetrates biotissue to a depth of zo ~ 1/A. Owing to absorption of radiation, biotissue gets heated by an amount of Δ T, and then cools by diffusion during the time
Figure imgf000007_0001
where X is the thermal diffusivity, and the laser beam diameter a is taken, for the sake of definiteness, to be greater than zo . By way of illustration, let us consider soft biotissue with A ~ 10 cm-1 and X ~ 1.3x10-3 cm2/s. The cooling time in this case is T cool , 2 s. Consequently, by using a laser pulse with a duration of Tp < Tcool one can, according to the data of Figure 1, heat the tissue by Δ Tmax = 5-10°C without running any risk of it being damaged. This limits the fluence of a laser pulse with a duration of Tp < T cool to a value of
Φ < Φmax ~ Tmax ρc/ηo (2) where P and c are the density and heat capacity of biotissue, respectively, and η o < A. In our example,
Φ max ~ 4 J/cm2, which corresponds to a maximum permissible average laser intensity of =Φmax/Tcool
Figure imgf000007_0002
~ 2 V/cm2
Biotissue has local absorption inhomogeneities of varying size: of the order of a few nanometers (biomolecules), a few tens of nanometers (biomolecular aggregation, membrane thickness), a few microns (cells and subcellular units), and more (microcapillaries). If a local absorption microregion has an absorptivity of δη loc exceeding the volume-averaged absorptivity η o ' it can be heated with a laser pulse by an amount of δT1oc exceeding the volume-averaged heating Δ T. The cooling time T1 oc of the local overheating microregion is determined by its size 1: T1oc ~ I2/4x ( 3 )
If the laser pulse duration Tp is shorter than this cooling time, the amount of local overheating will then be δT1oc =ΔT(δη1 oc/ηo) (4) For example, the cooling time of a local absorption microregion of size 1 ~ 30 nm = 3x10-6 cm is T1oc ~
2x10-9 s. Consequently, to effect a pulsed local heating of such a microregion, the duration Tp of the laser pulse used must be shorter than 2 ns. If the laser pulse fluence permissible from the standpoint of the volume- averaged non-destructive heating is, according to the above numerical example, Φ maχ ~ 4 J/cm2, the peak intensity of the ultrashort laser pulse is 1p ~ Φmax /Tρ ~ 2 x 109 W/CM2. This intensity value is quite permissible, but it is fairly close to the threshold marking the onset of multiple-photon absorption effects. Even if the contrast of local absorption against the background of average absorption,K=δη1oc /ηo is low, one can achieve a noticeable pulsed overheating (δT1oc ~ = 15- 50°) of local absorption microregions for a time of T1oc ~ 2 ns , the average heating of biotissue being quite insignificant ( Δ T ~ 5-10°C). The time interval between successive ultrashort laser pulses, T rep, must be longer than the cooling time T cool of the entire laser-exposed bulk of biotissue. In the above numerical example, T cool ~ 2s.
To effect a selective pulsed heating of microregions of smaller size, the laser pulse duration must be shorter, in accordance with equation (3), and to prevent multiple-photon effects in the bulk of biotissue, the laser energy must be distributed among several pulses within the time interval T cool' so as to ensure that the peak intensity does not perceptibly exceed the value of 1P ~ 2x109 W/cm2. Similarly, to achieve a local pulsed heating of larger microregions, one can use, in accordance with equation (3), longer pulses, and since the peak laser intensity will be lower than 109 W/cm2, radiation energy can be deposited in biotissue with single pulses. The interval between them in this case must not exceed Tcool in order to avoid destructive volume-averaged heating of biotissue. Figure 3a shows the laser pulse sequence and Figure 3b, the temporal variation of the temperature of the exposed medium, caused by both the local heating δ T 1oc of the microregions of increased absoption and the volume- averaged heating ΔT of the tissue. The volume-averaged laser heating can accumulate during a long period of Tcool , if the cooling time is much longer than the interval Trep between the pulses. At the same time, the local heating of the microregions of increased absorption rapidly vanishes within the time T1oc << Trep . τhe average heating Δ T of the exposed region during the timeTcool must not exceed a maxium value of ΔTmax.
The therapeutic effect of laser pulses is due to, first, the local pulsed non-destructive heating of microregions in the laser-exposed biotissue by the amount defined by equation (4) and secondly, the production of the pulsed temperature gradients d ΔT/d z ~ δ T1oc/1 = (ΔT/1 (δη1oc/ηo) (5) that no other method can provide. Both these effects influence materially the course of metabolic processes on the molecular, subcellular, cellular, and above-cellular levels.
The above arguments define the region of laser radiation parameters with which pulsed laser photothermotherapy can be realised. This region is denoted by the symbol IV in Figure 2. These considerations also determine the choice of the parameters the device for implementing the technique must have.
A device for laser photothermotherapy is shown in Figure 4 and includes a pulsed laser 1 whose wavelength λ corresponds to that of local absorption by microregions of average size 1 (λ) in biotissue, a laser pulse duration control unit 2 providing for the generation of laser pulses with a duration of TP satisfying the condition
T P < T1oc=/2(λ)/4X (6) and a repetition period of T rep meeting the requirement for the absence of any noticeable volume-averaged heating of biotissue:
Trep <Tcool =
Figure imgf000010_0001
(λ)/4X <1/[4η
Figure imgf000010_0002
(λ) ]X (7) a delivery system 3 to deliver radiation to a biotissue treatment region that ensures the necessary laser pulse fluence Φp ~ ΔT max Pc/ηo ( 8 ) with which the volume-averaged heating of biotissue falls within permissible limits, Δ Tmax ' while the pulsed local heating of the microregions in the tissue reaches therapeutic levels (δT1oc > 15-50°C), and a rise and fall measurement unit 4 for measuring the local heating by a single laser pulse and the average heating ΔT by a train of laser pulses, which controls, by way of feedback to the control unit 2, the pulse energy and repetition period and the total exposure dose in order to provide for therapeutic effect without running the risk of thermal damage to the exposed tissue region. For this purpose, use can be made, for example, of a small-time- constant radiometer registering the heat emission intensity of the heated tissue regions. To measure the pulsed heating of local microregions, use is made of the fast component (1 in Figure 3b) of the temperature variation following the laser pulse, whereas the volume- averaged heating is determined from the slow temperature variation component (2 in Figure 3b).
It will be understood that the construction and parameters of the units 1, 2, 3, 4 will be clear- to those skilled in the associated art and, therefore, do not require detailed description in this specification.
Table 1
An example of selecting laser pulse parameters for the laser photothermotherapy of biotissue withfe. = 10 Cm-1 and X = 1.3x10-3 cm2 /s as a function of the average size 1(λ) of local microregions of increased absorption
Figure imgf000011_0001
Table 1 lists the laser pulse parameters necessary for treating biotissue, for example, with an absorptivity of η o = 10 cm-1 and a thermal diffusivity of X = 1.3x10- 3 cm2/s, as a function for the average size 1 (λ ) of local microregions of increased absorption at the laser wavelength λ . For 1 > 30 n = 300 A, the laser pulse repetition period is determined by the cooling time Tcool' whereas for 1 < 30 n, the pulse repetition period is selected to be shorter in order to limit the peak pulse intensity to a non-destructive level of some 2x109 W/cm2 . In that case, the laser pulse fluence is limited to a safe average heating level of around 4 J/cm2.
The device can also be used in a method of laser photothermotherapy where tissue is injected by exogenak non-toxic dye or drug comprised by chromophores of suitable size to enable local micro-heating, on absorbing the effective wavelength, of the microregion where the chromophores of the dye or drug are situated and cause therapeutic or destructive effects according to the condition treated.

Claims

CLAIMS :
1. A device for laser photothermotherapy comprising a pulsed laser constructed to operate in the ultraviolet, visible or infrared part of the spectrum, and a system arranged to deliver pulsed irradiation generated from said laser to a targeted area of living human or animal tissue, characterised in that control means (2) are provided for controlling said laser (1) to generate pulses of variable duration, repetition rate and pause duration between the pulses, and that measuring means (4) responsive to the tissue, when irradiated, are provided for operating said control means for the pulse duration and wavelength delivered by said laser to correspond to the size and nature of one or more targeted absorbing exogenous or endogenous chromophores in the tissue, said measuring means being responsive to local microheating of an absorbing said chromophore or chromophores and the surrounding local microregion, significantly higher than the average temperature of the entire targeted tissue, for actuating said control means to render the pauses between consecutive laser pulses to be sufficiently long to permit cooling of the temperature elevation in said local microregion between each pulse and the next.
2. A device according to Claim 1, characterised in that said measuring means (4) comprises a short-time constant radiometer arranged to register the heat emission of the tissue region, when targeted, the radiometer comprising a fast component to measure pulsed heating of local microregions following each laser pulse and a slow temperature variation component for detecting volume-averaged heating of the targeted area.
3. A device according to Claim 1 or Claim 2, characterised in that said control system is contrived for each pulse to have a duration complying with the relation TP < T1oc=I2(y)/4X and for each pulse to have energy complying with the relations
Φ < Φ max ~ ΔTmax Pc/η
and
δT1oc = ΔT (δη1oc/ηo)
4. A method of effective laser photothermotherapy comprising delivering ultraviolet, visible or infrared laser pulse energy to a targeted area of living human or animal tissue characterised in that the method is effected by means of a device according to any one of the preceding claims.
PCT/GB1991/000862 1990-05-30 1991-05-30 A device and method for laser photothermotherapy WO1991018646A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909011998A GB9011998D0 (en) 1990-05-30 1990-05-30 A device and method for laser photothermotherapy
GB9011998.3 1990-05-30

Publications (1)

Publication Number Publication Date
WO1991018646A1 true WO1991018646A1 (en) 1991-12-12

Family

ID=10676737

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1991/000862 WO1991018646A1 (en) 1990-05-30 1991-05-30 A device and method for laser photothermotherapy

Country Status (3)

Country Link
EP (1) EP0485570A1 (en)
GB (1) GB9011998D0 (en)
WO (1) WO1991018646A1 (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003793A1 (en) * 1991-08-22 1993-03-04 Roberto Enzo Di Biaggio Medical light treatment apparatus
WO1994028972A1 (en) * 1993-05-14 1994-12-22 Eberhard Oppold Safety laser beam apertures (sla) for therapeutic and diagnostic medical equipment
WO1996017656A1 (en) * 1994-12-09 1996-06-13 Cynosure, Inc. Near-infrared selective photothermolysis for vascular targets
WO1997046280A1 (en) * 1996-06-07 1997-12-11 Biolight Patent Holding Ab Device for external treatment with pulsating light of high duty cycle
WO1997046279A1 (en) * 1996-06-07 1997-12-11 Biolight Patent Holding Ab A device for external medical treatment with monochromatic light
WO1998003224A1 (en) * 1996-07-19 1998-01-29 Theratechnologies R & D Inc. Irradiating apparatus using a scanning light source for photodynamic treatment
EP0846477A1 (en) * 1996-12-05 1998-06-10 Centre International De Recherches Dermatologiques Galderma (C.I.R.D. Galderma) Chromophor use in a composition suitable to be used on the skin in conjonction with laser treatment
WO1998052644A1 (en) * 1997-05-23 1998-11-26 Hofmann Guenther System for photodynamic therapy of living organisms and their organs and/or tissues
US5843072A (en) * 1996-11-07 1998-12-01 Cynosure, Inc. Method for treatment of unwanted veins and device therefor
US5871479A (en) * 1996-11-07 1999-02-16 Cynosure, Inc. Alexandrite laser system for hair removal and method therefor
DE19954710C1 (en) * 1999-11-17 2001-03-15 Pulsion Medical Sys Ag Apparatus for treatment of blood vessels especially in eye, comprises laser to deliver structured beam and monitor system to measure concentration of chromophoric agents for system control
US6228075B1 (en) 1996-11-07 2001-05-08 Cynosure, Inc. Alexandrite laser system for hair removal
WO2001047601A1 (en) * 1999-12-28 2001-07-05 Antonia Villalon Castilla Thermostimulation apparatus for therapeutic treatments
EP1637182A1 (en) * 2003-06-20 2006-03-22 Keio University Photodynamic therapy apparatus, method for controlling photodynamic therapy apparatus, and photodynamic therapy method
WO2007057017A1 (en) * 2005-11-16 2007-05-24 Aalborg Universitet Light modulation of cell function
WO2013169180A1 (en) * 2012-05-07 2013-11-14 Biolight Patent Holding Ab Device for external medical treatment using light of varying pulse lengths
US8915948B2 (en) 2002-06-19 2014-12-23 Palomar Medical Technologies, Llc Method and apparatus for photothermal treatment of tissue at depth
US9028536B2 (en) 2006-08-02 2015-05-12 Cynosure, Inc. Picosecond laser apparatus and methods for its operation and use
US9550070B2 (en) 2012-06-15 2017-01-24 Aptar France S.A.S. Light pen dispenser
US9780518B2 (en) 2012-04-18 2017-10-03 Cynosure, Inc. Picosecond laser apparatus and methods for treating target tissues with same
US10245107B2 (en) 2013-03-15 2019-04-02 Cynosure, Inc. Picosecond optical radiation systems and methods of use
US10434324B2 (en) 2005-04-22 2019-10-08 Cynosure, Llc Methods and systems for laser treatment using non-uniform output beam
US11418000B2 (en) 2018-02-26 2022-08-16 Cynosure, Llc Q-switched cavity dumped sub-nanosecond laser

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2000335A (en) * 1977-06-20 1979-01-04 Rca Corp Apparatus for hyperthermia treatment
DE3134953A1 (en) * 1981-09-03 1983-03-10 Schmid, geb.Bühl, Annemarie, 7914 Pfaffenhofen Infrared irradiation device
WO1986000515A1 (en) * 1982-06-28 1986-01-30 The Johns Hopkins University Electro-optical device and method for monitoring singlet oxygen produced photoradiation using pulsed excitation and time domain signal processing
US4950268A (en) * 1987-02-27 1990-08-21 Xintec Corporation Laser driver and control circuit

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2000335A (en) * 1977-06-20 1979-01-04 Rca Corp Apparatus for hyperthermia treatment
DE3134953A1 (en) * 1981-09-03 1983-03-10 Schmid, geb.Bühl, Annemarie, 7914 Pfaffenhofen Infrared irradiation device
WO1986000515A1 (en) * 1982-06-28 1986-01-30 The Johns Hopkins University Electro-optical device and method for monitoring singlet oxygen produced photoradiation using pulsed excitation and time domain signal processing
US4950268A (en) * 1987-02-27 1990-08-21 Xintec Corporation Laser driver and control circuit

Cited By (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003793A1 (en) * 1991-08-22 1993-03-04 Roberto Enzo Di Biaggio Medical light treatment apparatus
WO1994028972A1 (en) * 1993-05-14 1994-12-22 Eberhard Oppold Safety laser beam apertures (sla) for therapeutic and diagnostic medical equipment
US5749868A (en) * 1994-12-09 1998-05-12 Cynosure, Inc. Near infra-red selective photothermolysis for ectatic vessels and method therefor
WO1996017656A1 (en) * 1994-12-09 1996-06-13 Cynosure, Inc. Near-infrared selective photothermolysis for vascular targets
WO1997046279A1 (en) * 1996-06-07 1997-12-11 Biolight Patent Holding Ab A device for external medical treatment with monochromatic light
US6238424B1 (en) 1996-06-07 2001-05-29 Biolight Patent Holding Ab Device for external treatment with pulsating light of high duty cycle
US6238425B1 (en) 1996-06-07 2001-05-29 Biolight Patent Holding Ab Device for external medical treatment with monochromatic light
WO1997046280A1 (en) * 1996-06-07 1997-12-11 Biolight Patent Holding Ab Device for external treatment with pulsating light of high duty cycle
WO1998003224A1 (en) * 1996-07-19 1998-01-29 Theratechnologies R & D Inc. Irradiating apparatus using a scanning light source for photodynamic treatment
US5798523A (en) * 1996-07-19 1998-08-25 Theratechnologies Inc. Irradiating apparatus using a scanning light source for photodynamic treatment
AU721100B2 (en) * 1996-07-19 2000-06-22 Celmed Biosciences Inc. Irradiating apparatus using a scanning light source for photodynamic treatment
US6228075B1 (en) 1996-11-07 2001-05-08 Cynosure, Inc. Alexandrite laser system for hair removal
US6632218B1 (en) 1996-11-07 2003-10-14 Cynosure, Inc. Alexandrite laser system for hair removal and method therefor
US5843072A (en) * 1996-11-07 1998-12-01 Cynosure, Inc. Method for treatment of unwanted veins and device therefor
US5871479A (en) * 1996-11-07 1999-02-16 Cynosure, Inc. Alexandrite laser system for hair removal and method therefor
US6045548A (en) * 1996-11-07 2000-04-04 Cynosure, Inc. Alexandrite laser system for hair removal and method therefor
AU699637B2 (en) * 1996-12-05 1998-12-10 C.I.R.D. Galderma Use of a chromophore in a composition intended to be applied to the skin before a laser treatment
FR2756741A1 (en) * 1996-12-05 1998-06-12 Cird Galderma USE OF A CHROMOPHORE IN A COMPOSITION INTENDED TO BE APPLIED TO THE SKIN BEFORE LASER TREATMENT
US6086580A (en) * 1996-12-05 2000-07-11 Centre International De Recherches Dermatologiques Laser treatment/ablation of skin tissue
EP0846477A1 (en) * 1996-12-05 1998-06-10 Centre International De Recherches Dermatologiques Galderma (C.I.R.D. Galderma) Chromophor use in a composition suitable to be used on the skin in conjonction with laser treatment
WO1998052644A1 (en) * 1997-05-23 1998-11-26 Hofmann Guenther System for photodynamic therapy of living organisms and their organs and/or tissues
US6491715B1 (en) 1999-11-17 2002-12-10 Pulsion Medical Systems Ag Device for treating growing, dilated or malformed blood vessels and method for treating biological material
EP1101450A1 (en) 1999-11-17 2001-05-23 Pulsion Medical Systems AG Device and method for treating growing, dilated or malformed blood vessels
DE19954710C1 (en) * 1999-11-17 2001-03-15 Pulsion Medical Sys Ag Apparatus for treatment of blood vessels especially in eye, comprises laser to deliver structured beam and monitor system to measure concentration of chromophoric agents for system control
WO2001047601A1 (en) * 1999-12-28 2001-07-05 Antonia Villalon Castilla Thermostimulation apparatus for therapeutic treatments
US8915948B2 (en) 2002-06-19 2014-12-23 Palomar Medical Technologies, Llc Method and apparatus for photothermal treatment of tissue at depth
US10556123B2 (en) 2002-06-19 2020-02-11 Palomar Medical Technologies, Llc Method and apparatus for treatment of cutaneous and subcutaneous conditions
US10500413B2 (en) 2002-06-19 2019-12-10 Palomar Medical Technologies, Llc Method and apparatus for treatment of cutaneous and subcutaneous conditions
EP1637182A1 (en) * 2003-06-20 2006-03-22 Keio University Photodynamic therapy apparatus, method for controlling photodynamic therapy apparatus, and photodynamic therapy method
EP1637182A4 (en) * 2003-06-20 2007-09-05 Univ Keio Photodynamic therapy apparatus, method for controlling photodynamic therapy apparatus, and photodynamic therapy method
US10434324B2 (en) 2005-04-22 2019-10-08 Cynosure, Llc Methods and systems for laser treatment using non-uniform output beam
WO2007057017A1 (en) * 2005-11-16 2007-05-24 Aalborg Universitet Light modulation of cell function
US10849687B2 (en) 2006-08-02 2020-12-01 Cynosure, Llc Picosecond laser apparatus and methods for its operation and use
US10966785B2 (en) 2006-08-02 2021-04-06 Cynosure, Llc Picosecond laser apparatus and methods for its operation and use
US11712299B2 (en) 2006-08-02 2023-08-01 Cynosure, LLC. Picosecond laser apparatus and methods for its operation and use
US9028536B2 (en) 2006-08-02 2015-05-12 Cynosure, Inc. Picosecond laser apparatus and methods for its operation and use
US10305244B2 (en) 2012-04-18 2019-05-28 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US9780518B2 (en) 2012-04-18 2017-10-03 Cynosure, Inc. Picosecond laser apparatus and methods for treating target tissues with same
US11664637B2 (en) 2012-04-18 2023-05-30 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US10581217B2 (en) 2012-04-18 2020-03-03 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US11095087B2 (en) 2012-04-18 2021-08-17 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
WO2013169180A1 (en) * 2012-05-07 2013-11-14 Biolight Patent Holding Ab Device for external medical treatment using light of varying pulse lengths
US9550070B2 (en) 2012-06-15 2017-01-24 Aptar France S.A.S. Light pen dispenser
US10765478B2 (en) 2013-03-15 2020-09-08 Cynosurce, Llc Picosecond optical radiation systems and methods of use
US11446086B2 (en) 2013-03-15 2022-09-20 Cynosure, Llc Picosecond optical radiation systems and methods of use
US10245107B2 (en) 2013-03-15 2019-04-02 Cynosure, Inc. Picosecond optical radiation systems and methods of use
US10285757B2 (en) 2013-03-15 2019-05-14 Cynosure, Llc Picosecond optical radiation systems and methods of use
US11418000B2 (en) 2018-02-26 2022-08-16 Cynosure, Llc Q-switched cavity dumped sub-nanosecond laser
US11791603B2 (en) 2018-02-26 2023-10-17 Cynosure, LLC. Q-switched cavity dumped sub-nanosecond laser

Also Published As

Publication number Publication date
EP0485570A1 (en) 1992-05-20
GB9011998D0 (en) 1990-07-18

Similar Documents

Publication Publication Date Title
WO1991018646A1 (en) A device and method for laser photothermotherapy
JP4187799B2 (en) Method and apparatus for providing rapid and deep spatially selectable coagulation during a heat mediated therapy process
Peavy Lasers and laser–tissue interaction
US7238183B2 (en) System and method for treating skin
US8317779B2 (en) Methods and systems for laser treatment using non-uniform output beam
US5643334A (en) Method and apparatus for the diagnostic and composite pulsed heating and photodynamic therapy treatment
US7097639B1 (en) Dual filter multiple pulse photo-dermatological device with pre/post optical heating, quasi-logarithmic spacing, and laser rod spectrum infusion
US6235015B1 (en) Method and apparatus for selective hair depilation using a scanned beam of light at 600 to 1000 nm
US5595568A (en) Permanent hair removal using optical pulses
Janda et al. Comparison of thermal tissue effects induced by contact application of fiber guided laser systems
EP0765673A2 (en) Method and apparatus for treatment of cancer using pulsed electromagnetic radiation
US8882752B2 (en) Aesthetic treatment device
CA2279346A1 (en) Peltier cooled apparatus and methods for dermatological treatment
JPS60190969A (en) Heating apparatus for hyperthermia
Lee et al. Principles and choice of laser treatment in dermatology
Matthewson et al. Comparison of continuous-wave and pulsed excitation for interstitial neodymiurn-YAG laser-induced hyperthermia
Saeed et al. Theoretical Model for Temperature Distribution Resulting from CW-Laser Radiation Heats up Tumor Tissues.
Mueller et al. Main problems and new results on dosimetry in laser medicine
WO2001087408A2 (en) Method and apparatus for applying electromagnetic radiation into human tissues for producing a therapeutic effect
Pustovalov et al. Melanin granule models for the processes of laser-induced thermal damage in pigmented retinal tissues. I. Modeling of laser-induced heating of melanosomes and selective thermal processes in retinal tissues
Amesawi et al. PRIMARY INVESTIGATION ON POTENTIAL INTERACTION OF AN ER: YAG LASER SYSTEM WITH SKIN
Thompson et al. Gruneisen equation of state for melanosomes irradiated by subnanosecond laser pulses
Chen Experimental and modeling study of thermal response of skin and cornea to infrared wavelengths laser irradiation
Hibst Mechanisms of ultraviolet and mid-infrared tissue ablation
Trelles et al. PHOTOTHERAPY UNVEILED: A REVIEW OF THE PHOTOBIOLOGICAL BASICS BEHIND ATHERMAL PHOTOBIOMODULATION WITH LASERS AND OTHER LIGHT SOURCES. PART 1: LIGHT-ITS PROPERTIES AND PARAMETERS

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1991910683

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1991910683

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 1991910683

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1991910683

Country of ref document: EP